跳至主要内容
临床试验/CTRI/2022/05/042657
CTRI/2022/05/042657招募中未知

The Descriptive Study on Assessment of the effects of combination of SGLT 2 Inhibitors (SGLT2-I) and Renin Angiotensin Aldosterone System (RAAS) Blockers (RAAS-I) on the renal functions of patients of diabetic kidney disease (DKD) on the population of patients from the Southern part of West Bengal (SGRAAS-DKD) - SGRAAS-DKD

Thakurpukur Medical Society0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Diagnosed case of Diabetic Kidney Disease
  • Type 2 Diabetes Mellitus with
  • a. Urinary Spot ACR > 30 mg/g
  • b. eGFR, calculated by CKD-EPI < 90 mL/min/1.73 M2
  • c. Receiving RAAS-I for at least 4 weeks
  • d. Recently initiated on SGLT2-I

排除标准

  • 1.eGFR, calculated by CKD-EPI <30 mL/min/1.73 M2
  • 2.Non-consenting patients
  • 3.Doubt about the nature of kidney disease. Suspicion of nondiabetic renal disease such as renal artery stenosis, glomerular disease or other systemic disorders with renal involvement
  • 4.Ongoing active infection, sepsis or symptomatic UTI, active malignancy
  • 5.History of symptomatic UTI in the past 6 months

研究者

发起方
Thakurpukur Medical Society

相似试验